Media

FeaturesFebruary 19, 2021

Dr. Reid Robison on Our Purpose-Driven Mission to Help People who are Suffering

Agoracom interviewed our Chief Medical Officer about our latest expansions, the striking results from treatments, and what it takes to build infrastructure for psychedelic-assisted healthcare.

FeaturesFebruary 18, 2021

Novamind Leading The Charge To Deliver Mental Health Alternatives

Psychedelic Invest published an article about the urgent need for innovative mental health treatments, and the companies working to meet that need.

FeaturesFebruary 07, 2021

Therapy With Substance

Investors are rarely offered an opportunity to participate in a nascent, multi-billion dollar, industry

FeaturesFebruary 07, 2021

Novamind's Dr. Reid Robison on Building a Network for Psychedelic Medicine

With years of experience studying and administering ketamine, Dr. Robison discusses psychedelic infrastructure and the change it can create

MultimediaJanuary 27, 2021

The Wall Street Reporter Interviewed Novamind's CEO, Yaron Conforti

Yaron Conforti talks to Wall Street Reporter about Novamind's operations and plans for the future

OpinionJanuary 23, 2021

Psychedelics and Eating Disorders

How new treatment modalities are urgently needed to address these unmet needs